Table 2.

Clinical outcome following HSCT: summary of univariate analyses

Outcome	Explanatory variable	Test	Statistic	df	p-Value
Overall survival (OS)	geno50	Log-Rank	1.72	2	0.42
	geno50.bis	Log-Rank	1.54	1	0.22
	geno20	Log-Rank	1.21	1	0.27
Relapse/progression	geno50	χ2	2.32	2	0.31
	geno50.bis	Fisher	–	–	0.68 (two-sided)
	geno20	Fisher	–	–	>0.99 (two-sided)
aGVHD	geno50	χ2	0.69	4	0.95
	geno50.bis	χ2	0.5	2	0.78
	geno20	χ2	0.63	2	0.73
cGVHD	geno50	χ2	1.38	2	0.5
	geno50.bis	Fisher	–	–	0.83 (two-sided)
	geno20	Fisher	–	–	0.27 (two-sided)
Survival status at this date	geno50	χ2	7.55	4	0.11
	geno50.bis	χ2	6.59	2	0.04
	geno20	χ2	1.08	2	0.58
Overall survival (OS)	DPB1 matching	Log-Rank	0.52	2	0.77
aGVHD	DPB1 matching	χ2	7.64	2	0.02
Relapse/progression	DPB1 matching	χ2	7.01	2	0.03

Geno50: recipients carrying 2, 1 or 0 common haplotypes with a frequency ≤ rank 50; geno50.bis: recipients carrying 2 common haplotypes with a frequency ≤ rank 50 versus recipients carrying any rare haplotypes with a frequency > rank 50; geno20: recipients carrying 0 or 1 rare haplotype versus recipients carrying 2 rare haplotypes with a frequency > rank 20

aGVHD acute graft vesus host disease, cGVHD chronic graft versus host disease, df degrees of freedom